Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation
Authors:
- Jonas A. GustafsonJGJonas A. Gustafson
- Sophia B. GibsonSGSophia B. Gibson
- Nikhita DamarajuNDNikhita Damaraju
- Miranda Pg ZaluskyMZMiranda Pg Zalusky
- Kendra HoekzemaKHKendra Hoekzema
- David TwesigomweDTDavid Twesigomwe
- Lei YangLYLei Yang
- Anthony A. SneadASAnthony A. Snead
- Phillip A. RichmondPRPhillip A. Richmond
- Wouter De CosterWCWouter De Coster
- Nathan D. OlsonNONathan D. Olson
- Andrea GuarracinoAGAndrea Guarracino
Preprint
Abstract
Less than half of individuals with a suspected Mendelian condition receive a precise molecular diagnosis after comprehensive clinical genetic testing. Improvements in data quality and costs have heightened interest in using long-read sequencing (LRS) to streamline clinical genomic testing, but the absence of control datasets for variant filtering and prioritization has made tertiary analysis of LRS data challenging. To address this, the 1000 Genomes Project ONT Sequencing Consortium aims to generate LRS data from at least 800 of the 1000 Genomes Project samples. Our goal is to use LRS to identify a broader spectrum of variation so we may improve our understanding of normal patterns of human variation. Here, we present data from analysis of the first 100 samples, representing all 5 superpopulations and 19 subpopulations. These samples, sequenced to an average depth of coverage of 37x and sequence read N50 of 54 kbp, have high concordance with previous studies for identifying single nucleotide and indel variants outside of homopolymer regions. Using multiple structural variant (SV) callers, we identify an average of 24,543 high-confidence SVs per genome, including shared and private SVs likely to disrupt gene function as well as pathogenic expansions within disease-associated repeats that were not detected using short reads. Evaluation of methylation signatures revealed expected patterns at known imprinted loci, samples with skewed X-inactivation patterns, and novel differentially methylated regions. All raw sequencing data, processed data, and summary statistics are publicly available, providing a valuable resource for the clinical genetics community to discover pathogenic SVs.Keywords
All Related Versions
- Published version: Genome Research, 34 (11), 2061.
This publication has 72 references indexed in Scilit:
- Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African PopulationsClinical Pharmacology & Therapeutics, 2023
- Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African PopulationsClinical Pharmacology & Therapeutics, 2022
- High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 triosCell, 2022
- Targeted long-read sequencing identifies missing disease-causing variationThe American Journal of Human Genetics, 2021
- 30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?The American Journal of Human Genetics, 2021
- Expectations and blind spots for structural variation detection from long-read assemblies and short-read genome sequencing technologiesThe American Journal of Human Genetics, 2021
- Characterizing the Major Structural Variant Alleles of the Human GenomeCell, 2019
- DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl ResourcesThe American Journal of Human Genetics, 2009
- Reduced Penetrance in a Brazilian Family With Spinocerebellar Ataxia Type 10Archives of Neurology, 2007
- Hemoglobin Kenya, the product of fusion of γ and β polypeptide chainsArchives of Biochemistry and Biophysics, 1972